Keros Therapeutics
Aadhar Mahajan is an experienced project management professional currently serving as Associate Director of Program Management at Immunovant since May 2024. Previously, Aadhar held the position of Senior Manager of Project Management at Avenge Bio, where responsibilities included managing clinical phase cell therapy projects and supporting IND submissions. Aadhar also served as Manager of Portfolio & Program Management at Sigilon Therapeutics, guiding successful IND and CTA filings and performing portfolio reviews. Earlier roles included a Program Planning Analyst at Karyopharm Therapeutics and various positions focused on clinical data at ECOG-ACRIN Cancer Research Group and Brigham and Women's Hospital. Aadhar earned an MBA from Questrom School of Business, Boston University, and a Bachelor of Science in Biology with a minor in Economics from Boston College.
This person is not in any teams
Keros Therapeutics
2 followers
Keros is dedicated to discovery and development of novel therapeutics for hematological and musculoskeletal disorders.